AdaptHealth Corp. (AHCO)
AdaptHealth Statistics
Share Statistics
AdaptHealth has 134.87M shares outstanding. The number of shares has increased by 1.25% in one year.
| Shares Outstanding | 134.87M |
| Shares Change (YoY) | 1.25% |
| Shares Change (QoQ) | 0.23% |
| Owned by Institutions (%) | 97.57% |
| Shares Floating | 86.6M |
| Failed to Deliver (FTD) Shares | 1.75K |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 8.42M, so 6.24% of the outstanding shares have been sold short.
| Short Interest | 8.42M |
| Short % of Shares Out | 6.24% |
| Short % of Float | 8.16% |
| Short Ratio (days to cover) | 4.11 |
Valuation Ratios
The PE ratio is 14.08 and the forward PE ratio is 6.61. AdaptHealth's PEG ratio is -0.13.
| PE Ratio | 14.08 |
| Forward PE | 6.61 |
| PS Ratio | 0.39 |
| Forward PS | 0.2 |
| PB Ratio | 0.81 |
| P/FCF Ratio | 5.4 |
| PEG Ratio | -0.13 |
Enterprise Valuation
AdaptHealth has an Enterprise Value (EV) of 1.33B.
| EV / Sales | 0.41 |
| EV / EBITDA | 4.38 |
| EV / EBIT | 2.45 |
| EV / FCF | 5.64 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.33 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 0.7 |
| Interest Coverage | 2.08 |
Financial Efficiency
Return on Equity is 5.76% and Return on Invested Capital is 4.62%.
| Return on Equity | 5.76% |
| Return on Assets | 2.02% |
| Return on Invested Capital | 4.62% |
| Revenue Per Employee | $310.57K |
| Profits Per Employee | $8.61K |
| Employee Count | 10,500 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 18.45 |
Taxes
| Income Tax | 41.24M |
| Effective Tax Rate | 30.32% |
Stock Price Statistics
The stock price has increased by -15.76% in the last 52 weeks. The beta is 1.45, so AdaptHealth's price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | -15.76% |
| 50-Day Moving Average | 9.59 |
| 200-Day Moving Average | 10.16 |
| Relative Strength Index (RSI) | 43.33 |
| Average Volume (20 Days) | 1.69M |
Income Statement
In the last 12 months, AdaptHealth had revenue of 3.26B and earned 90.42M in profits. Earnings per share was 0.62.
| Revenue | 3.26B |
| Gross Profit | 681.09M |
| Operating Income | 263.73M |
| Net Income | 90.42M |
| EBITDA | 303.37M |
| EBIT | 262.69M |
| Earnings Per Share (EPS) | 0.62 |
Balance Sheet
The company has 109.75M in cash and 165.41M in debt, giving a net cash position of -55.67M.
| Cash & Cash Equivalents | 109.75M |
| Total Debt | 165.41M |
| Net Cash | -55.67M |
| Retained Earnings | -562.18M |
| Total Assets | 4.49B |
| Working Capital | 188.8M |
Cash Flow
In the last 12 months, operating cash flow was 541.84M and capital expenditures -306.06M, giving a free cash flow of 235.78M.
| Operating Cash Flow | 541.84M |
| Capital Expenditures | -306.06M |
| Free Cash Flow | 235.78M |
| FCF Per Share | 1.76 |
Margins
Gross margin is 20.89%, with operating and profit margins of 8.09% and 2.77%.
| Gross Margin | 20.89% |
| Operating Margin | 8.09% |
| Pretax Margin | 4.17% |
| Profit Margin | 2.77% |
| EBITDA Margin | 9.3% |
| EBIT Margin | 8.09% |
| FCF Margin | 7.23% |
Dividends & Yields
AHCO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 7.1% |
| FCF Yield | 18.52% |
Analyst Forecast
The average price target for AHCO is $14, which is 66.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 66.9% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 1.19 |
| Piotroski F-Score | 8 |